Fujioka S, Yamada T
Department of Haematology, Mitsui Memorial Hospital, Tokyo, Japan.
Br J Haematol. 1993 Apr;83(4):660-2. doi: 10.1111/j.1365-2141.1993.tb04707.x.
Using flow cytometry, decay-accelerating factor (DAF) and CD59 have been measured in peripheral blood cells of 11 patients with aplastic anaemia and 34 healthy controls. Ten of the patients had monophasic fluorescence profiles similar to those of the controls. However, one patient had small DAF- and CD59-negative populations in granulocytes and monocytes, but not in erythrocytes. One year after the first assay, a second flow cytometric study revealed that all peripheral blood cell species, including erythrocytes, contained DAF- and CD59-deficient populations. At this time, a sucrose haemolysis test was positive. This is the first reported case of aplastic anaemia-PNH syndrome in which DAF- and CD59-negative cells appeared first in granulocytes and monocytes and later in all types of peripheral blood cells.
运用流式细胞术,对11例再生障碍性贫血患者和34名健康对照者的外周血细胞中的衰变加速因子(DAF)和CD59进行了检测。10例患者具有与对照者相似的单相荧光图谱。然而,1例患者的粒细胞和单核细胞中有少量DAF和CD59阴性群体,但红细胞中没有。首次检测1年后,第二次流式细胞术研究显示,所有外周血细胞种类,包括红细胞,均含有DAF和CD59缺陷群体。此时,蔗糖溶血试验呈阳性。这是首例报告的再生障碍性贫血-阵发性睡眠性血红蛋白尿综合征病例,其中DAF和CD59阴性细胞首先出现在粒细胞和单核细胞中,随后出现在所有类型的外周血细胞中。